ORCID as entered in ROS

Select Publications
2009, '20. Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Journal of Clinical Neuroscience, 16, pp. 1531 - 1531, http://dx.doi.org/10.1016/j.jocn.2009.07.045
,2009, 'Editorial introductions', Current Opinion in Organ Transplantation, 14
,2009, 'Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease', Journal of Neuroinflammation, 6, pp. 1 - 13
,2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, 2, pp. 61 - 69
,2009, 'HIV, the brain, children, HAART and `neuro-HAART`: A complex mix', AIDS, 23, pp. 1909 - 1910
,2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes & neurons', Neurotoxicity Research, 16, pp. 77 - 86
,2009, 'Neurodegeneration and ageing in the HAART era', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 4, pp. 163 - 174
,2009, 'Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: A review', Neuropsychology Review, 19, pp. 169 - 185
,2009, 'P3‐195: Involvement of the kynurenine pathway in Alzheimer's disease', Alzheimer's & Dementia, 5, http://dx.doi.org/10.1016/j.jalz.2009.04.1069
,2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Neurology, 73, pp. 401 - 403
,2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons', PLoS One, 4, pp. e6344 -1 - 15
,2009, 'Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex', Archives of Clinical Neuropsychology, 24, pp. 165 - 178
,2008, 'Involvement of tryptophan catabolism during HIV-1 infection in primary culture of human monocytes-derived macrophages', FUNDAMENTAL & CLINICAL PHARMACOLOGY, 22, pp. 99 - 99, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256760500481&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Reply', Medical Journal of Australia, 188, pp. 489 - 490, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01732.x
,2008, 'A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy', AIDS Research and Human Retroviruses, 24, pp. 1027 - 1030
,2008, 'Biomarkers of HIV related central nervous system disease', International Review of Psychiatry, 20, pp. 73 - 88, http://dx.doi.org/10.1080/09540260701878082
,2008, 'Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity', Journal of Neurochemistry, 105, pp. 1346 - 1357, http://dx.doi.org/10.1111/j.1471-4159.2008.05241.x
,2008, 'NeuroAIDS in the Asia Pacific Region', Journal of Neurovirology, 14, pp. 465 - 473
,2008, 'Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region', Neurology, 71, pp. 50 - 56
,2008, 'Pathogenesis and diagnosis of viral infections of the nervous system', Neurologic Clinics, 26, pp. 617 - 617
,2008, 'Response to Birbeck et al', Epilepsia, 49, pp. 541 - 543
,2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors', British Journal of Pharmacology, 154, pp. 174 - 182, http://dx.doi.org/10.1038/bjp.2008.80
,2008, 'The involvement of astrocytes and kynurenine pathway in Alzheimer`s disease', Neurotoxicity Research, 12, pp. 247 - 262
,2008, 'The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia', HIV Medicine, 9, pp. 677 - 680
,2008, 'Tissue plasminogen activator for acute ischaemic stroke - Reply', Medical Journal of Australia, 188, pp. 489 - 490
,2007, 'AIDS dementia complex', Handbook of Clinical Neurology, 85, pp. 79 - 91, http://dx.doi.org/10.1016/S0072-9752(07)85006-8
,2007, 'Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex', Handbook of Clinical Neurology, 85, pp. 261 - 300, http://dx.doi.org/10.1016/S0072-9752(07)85017-2
,2007, 'Neurological sequelae of primary HIV infection', Handbook of Clinical Neurology, 85, pp. 69 - 77, http://dx.doi.org/10.1016/S0072-9752(07)85005-6
,2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-saharan Africa - Reply from the editorialists', NEUROLOGY, 69, pp. 412 - 413, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248243300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa [7]', Neurology, 69, pp. 412 - 413, http://dx.doi.org/10.1212/01.wnl.0000278073.28318.66
,2007, 'A protocol-driven model for the rapid initiation of stroke thrombolysis in the emergency department', Medical Journal of Australia, 187, pp. 567 - 570
,2007, 'Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection', Neurology, 69 (15), pp. 1536 - 1541
,2007, 'Characterization of the kynurenine pathway in human neurons', Journal of the History of the Neurosciences, 27, pp. 12884 - 12892
,2007, 'Characterization of the kynurenine pathway in human neurons', Journal of Neuroscience, 27, pp. 12884 - 12892
,2007, 'Characterization of the kynurenine pathway in primary human oligodendrocytes', International Congress Series, 1304, pp. 213 - 217
,2007, 'Chronic HIV infection leads to an Alzheimer’s disease like illness - Involvement of the kynurenine pathway', International Congress Series, 1304, pp. 324 - 334
,2007, 'Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment', HIV Medicine, 8, pp. 192 - 202
,2007, 'CSF neurofilament protein (NFL) - a marker of active HIV-related neurodegeneration', Journal of Neurology, 254, pp. 1026 - 1032
,2007, 'Defining and evaluating HIV-Related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2, pp. 112 - 119
,2007, 'Effect of Quinolinic acid on gene expression in human Astrocytes: Implications on Alzheimer’s disease', International Congress Series, 1304, pp. 384 - 388
,2007, 'Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex', Journal of Infectious Diseases, 195, pp. 1774 - 1778
,2007, 'Factors in AIDS dementia complex trial design: Results and lessons from the abacavir trial', PLoS Clinical Trials, 2
,2007, 'HAD and the need for new trial design methodology', AIDS, 21, pp. 1965 - 1966
,2007, 'HIV-associated dementia - An inconvenient truth', Neurology, 68, pp. 324 - 325
,2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival', European Journal of Neurology, 14, pp. 418 - 423
,2007, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone', Journal of Interferon and Cytokine Research, 27, pp. 53 - 64
,2007, 'Improved cognitive function as a consequence of hepatitis C virus treatment', HIV Medicine, 8, pp. 520 - 528
,2007, 'Lost in translation: Again, another failed neuroprotection trial', Neurology, 69, pp. 1308 - 1309
,2007, 'Mass spectrometric detection of quinolinic acid in microdissected Alzheimer disease plaques', International Congress Series, 1304, pp. 404 - 408
,2007, 'Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo', Retrovirology, 4 (66)
,